The Role of IGF/IGF-1R Signaling in Hepatocellular Carcinomas: Stemness-Related Properties and Drug Resistance
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of IGF/IGF-1R Signaling in Hepatocellular Carcinomas: Stemness-Related Properties and Drug Resistance
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 4, Pages 1931
Publisher
MDPI AG
Online
2021-02-16
DOI
10.3390/ijms22041931
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Niche Modulation of IGF-1R Signaling: Its Role in Stem Cell Pluripotency, Cancer Reprogramming, and Therapeutic Applications
- (2021) Pei-Chin Chen et al. Frontiers in Cell and Developmental Biology
- Gene Signature for Sorafenib Susceptibility in Hepatocellular Carcinoma: Different Approach with a Predictive Biomarker
- (2020) Chang Min Kim et al. Liver Cancer
- Initial Experience of Ramucirumab Treatment After Lenvatinib Failure for Patients With Advanced Hepatocellular Carcinoma
- (2020) TEIJI KUZUYA et al. ANTICANCER RESEARCH
- Activation of the HGF/c-MET axis promotes lenvatinib resistance in hepatocellular carcinoma cells with high c-MET expression
- (2020) Rongdang Fu et al. MEDICAL ONCOLOGY
- Aquaporin-9, Mediated by IGF2, Suppresses Liver Cancer Stem Cell Properties via Augmenting ROS/β-Catenin/FOXO3a Signaling
- (2020) Xi Zheng et al. MOLECULAR CANCER RESEARCH
- Efficacy and Safety of Ramucirumab in Asian and Non-Asian Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Individual Data Analysis of Two Randomized Studies
- (2020) Chia-Jui Yen et al. Liver Cancer
- Ramucirumab, A Second-Line Option For Patients With Hepatocellular Carcinoma: A Review Of The Evidence
- (2020) Emmanuele De Luca et al. Cancer Management and Research
- The Cancer Stem Cell in Hepatocellular Carcinoma
- (2020) Lucas-Alexander Schulte et al. Cancers
- Insulin Growth Factor Binding Protein 7 (IGFBP7)-Related Cancer and IGFBP3 and IGFBP7 Crosstalk
- (2020) Li Jin et al. Frontiers in Oncology
- An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness
- (2020) Mei-Yu Quan et al. Frontiers in Cell and Developmental Biology
- Cabozantinib for the Treatment of Advanced Hepatocellular Carcinoma: Current Data and Future Perspectives
- (2020) Jörg Trojan DRUGS
- Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy
- (2020) Hui Hua et al. Journal of Hematology & Oncology
- CCL22 signaling contributes to sorafenib resistance in hepatitis B virus-associated hepatocellular carcinoma
- (2020) Yanan Gao et al. PHARMACOLOGICAL RESEARCH
- Targeting SphK2 Reverses Acquired Resistance of Regorafenib in Hepatocellular Carcinoma
- (2020) Weiwei Shi et al. Frontiers in Oncology
- Projected prevalence and mortality associated with alcohol-related liver disease in the USA, 2019–40: a modelling study
- (2020) Jovan Julien et al. Lancet Public Health
- Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Andrew X Zhu et al. LANCET ONCOLOGY
- Cabozantinib: A Review in Advanced Hepatocellular Carcinoma
- (2019) Emma D. Deeks Targeted Oncology
- Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model
- (2019) Alastair Heffernan et al. LANCET
- Hepatocellular carcinoma in the setting of alcohol-related liver disease
- (2019) Nathalie Ganne-Carrié et al. JOURNAL OF HEPATOLOGY
- Distribution of insulin growth factor-1 (IGF-1) binding proteins in hepatocellular carcinoma with and without cirrhosis.
- (2019) Ahmed Abdelhakeem et al. JOURNAL OF CLINICAL ONCOLOGY
- YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role
- (2019) Matthias Van Haele et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Suppression of LSD1 enhances the cytotoxic and apoptotic effects of regorafenib in hepatocellular carcinoma cells
- (2019) Lin-wen Wu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts
- (2019) Myriam Alexander et al. BMC Medicine
- A novel, liver-specific long noncoding RNA LINC01093 suppresses HCC progression by interaction with IGF2BP1 to facilitate decay of GLI1 mRNA
- (2019) Jia He et al. CANCER LETTERS
- Insulin receptor isoform A favors tumor progression in human hepatocellular carcinoma by increasing stem/progenitor cell features
- (2019) Eva Benabou et al. CANCER LETTERS
- Hepatocellular Carcinoma
- (2019) Augusto Villanueva NEW ENGLAND JOURNAL OF MEDICINE
- Targeting Mybbp1a suppresses HCC progression via inhibiting IGF1/AKT pathway by CpG islands hypo-methylation dependent promotion of IGFBP5
- (2019) Xiaoyu Weng et al. EBioMedicine
- HBV-related hepatocarcinogenesis: the role of signalling pathways and innovative ex vivo research models
- (2019) Joseph Torresi et al. BMC CANCER
- Targeting the Interplay Between Cancer Fibroblasts, Mesenchymal Stem Cells, and Cancer Stem Cells in Desmoplastic Cancers
- (2019) Tze-Sian Chan et al. Frontiers in Oncology
- Enhancer of zeste 2 polycomb repressive complex 2 subunit promotes sorafenib resistance of hepatocellular carcinoma though insulin-like growth factor 1 receptor
- (2019) Jing Hu et al. ANTI-CANCER DRUGS
- Anti-tumoral activity of single and combined regorafenib treatments in preclinical models of liver and gastrointestinal cancers
- (2019) Flavia Fondevila et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- A global view of hepatocellular carcinoma: trends, risk, prevention and management
- (2019) Ju Dong Yang et al. Nature Reviews Gastroenterology & Hepatology
- Dedifferentiation process driven by radiotherapy-induced HMGB1/TLR2/YAP/HIF-1α signaling enhances pancreatic cancer stemness
- (2019) Lirong Zhang et al. Cell Death & Disease
- Inflammatory microenvironment contributes to stemness properties and metastatic potential of hepatocellular carcinoma via NF-κB/miR-497/SALL4 axis
- (2019) Bixing Zhao et al. Molecular Therapy-Oncolytics
- CRISPR Loss-of-Function Screen Identifies the Hippo Signaling Pathway as the Mediator of Regorafenib Efficacy in Hepatocellular Carcinoma
- (2019) Shigeki Suemura et al. Cancers
- LBA38_PRCheckMate 459: A randomized, multi-center phase III study of nivolumab (NIVO) vs sorafenib (SOR) as first-line (1L) treatment in patients (pts) with advanced hepatocellular carcinoma (aHCC)
- (2019) T Yau et al. ANNALS OF ONCOLOGY
- DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation
- (2019) Ssu-Chuan Lai et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The potential and controversy of targeting STAT family members in cancer
- (2019) Yannick Verhoeven et al. SEMINARS IN CANCER BIOLOGY
- The Hippo pathway integrates PI3K–Akt signals with mechanical and polarity cues to control tissue growth
- (2019) Nerea Borreguero-Muñoz et al. PLOS BIOLOGY
- MicroRNA-28-5p Regulates Liver Cancer Stem Cell Expansion via IGF-1 Pathway
- (2019) Qing Xia et al. Stem Cells International
- Macrophages-induced long noncoding RNA H19 up-regulation triggers and activates the miR-193b/MAPK1 axis and promotes cell aggressiveness in hepatocellular carcinoma
- (2019) Yingnan Ye et al. CANCER LETTERS
- IGFBP2 upregulates ZEB1 expression and promotes hepatocellular carcinoma progression through NF-κB signaling pathway
- (2019) Qiang Guo et al. DIGESTIVE AND LIVER DISEASE
- Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
- (2019) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of a unique loss-of-function mutation in IGF1R and a crosstalk between IGF1R and Wnt/β-catenin signaling pathways
- (2018) Gayatri Jamwal et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- A phase I trial of escalating doses of cixutumumab (IMC-A12) and sorafenib in the treatment of advanced hepatocellular carcinoma
- (2018) Anthony B. El-Khoueiry et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Multikinase Inhibitor CT-707 Targets Liver Cancer by Interrupting the Hypoxia-Activated IGF-1R–YAP Axis
- (2018) Hong Zhu et al. CANCER RESEARCH
- Serum from Chronic Hepatitis B Patients Promotes Growth and Proliferation via the IGF-II/IGF-IR/MEK/ERK Signaling Pathway in Hepatocellular Carcinoma Cells
- (2018) Yuanyuan Ji et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Non-alcoholic Steatohepatitis is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
- (2018) Zobair Younossi et al. Clinical Gastroenterology and Hepatology
- Combined treatment with sorafenib and silibinin synergistically targets both HCC cells and cancer stem cells by enhanced inhibition of the phosphorylation of STAT3/ERK/AKT
- (2018) Jie Mao et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Hepatitis B virus suppresses the secretion of insulin-like growth factor binding protein 1 to facilitate anti-apoptotic IGF-1 effects in HepG2 cells
- (2018) Kirstine Overgaard Nielsen et al. EXPERIMENTAL CELL RESEARCH
- Insulin-Like Growth Factor (IGF) System in Liver Diseases
- (2018) Agnieszka Adamek et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Chlorogenic Acid Improves the Regorafenib Effects in Human Hepatocellular Carcinoma Cells
- (2018) Maria Refolo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Association between non-alcoholic fatty liver disease and cancer incidence rate
- (2018) Gi-Ae Kim et al. JOURNAL OF HEPATOLOGY
- Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine
- (2018) Naoto Fujiwara et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- IGF1 receptor signaling pathways
- (2018) Fumihiko Hakuno et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
- (2018) Sheng-Nan Lu et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
- (2018) Andrew X Zhu et al. LANCET ONCOLOGY
- Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
- (2018) Ghassan K. Abou-Alfa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Loss of tumor suppressor IGFBP4 drives epigenetic reprogramming in hepatic carcinogenesis
- (2018) Ying-Ying Lee et al. NUCLEIC ACIDS RESEARCH
- Insulin-like growth factor-1 induces epithelial-mesenchymal transition in hepatocellular carcinoma by activating survivin
- (2018) Fangfeng Liu et al. ONCOLOGY REPORTS
- Ovatodiolide suppresses yes-associated protein 1-modulated cancer stem cell phenotypes in highly malignant hepatocellular carcinoma and sensitizes cancer cells to chemotherapy in vitro
- (2018) Hang-Lung Chang et al. TOXICOLOGY IN VITRO
- Inhibition of pMAPK14 Overcomes Resistance to Sorafenib in Hepatoma Cells with Hepatitis B Virus
- (2018) Dvora Witt-Kehati et al. Translational Oncology
- Mechanisms of Hepatitis B Virus Persistence
- (2018) Kuen-Nan Tsai et al. TRENDS IN MICROBIOLOGY
- Interplay between inflammatory tumor microenvironment and cancer stem cells (Review)
- (2018) Shijian Zhang et al. Oncology Letters
- Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types
- (2018) Prashant D. Tailor et al. Oncotarget
- IGF-Binding Proteins: Why Do They Exist and Why Are There So Many?
- (2018) John B. Allard et al. Frontiers in Endocrinology
- Insulin-Like Growth Factor Binding Proteins and IGFBP Proteases: A Dynamic System Regulating the Ovarian Folliculogenesis
- (2018) Sabine Mazerbourg et al. Frontiers in Endocrinology
- Validation of insulin-like growth factor-1 as a prognostic parameter in patients with hepatocellular carcinoma in a European cohort
- (2018) Yvonne Huber et al. BMC CANCER
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
- (2018) Fasiha Kanwal et al. GASTROENTEROLOGY
- Sox2 is associated with cancer stem-like properties in colorectal cancer
- (2018) Koki Takeda et al. Scientific Reports
- Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma
- (2018) Ruiqi Liu et al. CANCER LETTERS
- IGF-1 modulates gene expression of proteins involved in inflammation, cytoskeleton, and liver architecture
- (2017) VJ Lara-Diaz et al. JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Influence of higher BMI for hepatitis B- and C-related hepatocellular carcinomas
- (2017) Masakazu Hashimoto et al. LANGENBECKS ARCHIVES OF SURGERY
- Cancer stem cell niche models and contribution by mesenchymal stroma/stem cells
- (2017) Catharina Melzer et al. Molecular Cancer
- Low expression levels of insulin-like growth factor binding protein-3 are correlated with poor prognosis for patients with hepatocellular carcinoma
- (2017) Jinjin Yan et al. Oncology Letters
- Surface markers of liver cancer stem cells and innovative targeted-therapy strategies for HCC (Review)
- (2017) Lige Qiu et al. Oncology Letters
- Characteristics of patients with hepatitis B virus and hepatitis C virus dual infection in a Western European country: Comparison with monoinfected patients
- (2017) Astrid Marot et al. Clinics and Research in Hepatology and Gastroenterology
- 3D modeling of cancer stem cell niche
- (2017) Jun He et al. Oncotarget
- IGF-1 induces the epithelial-mesenchymal transition via Stat5 in hepatocellular carcinoma
- (2017) Chuanzong Zhao et al. Oncotarget
- C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway
- (2017) Rachel Hiu Ha Ching et al. Oncotarget
- The Roles of Insulin-Like Growth Factors in Mesenchymal Stem Cell Niche
- (2017) Amer Youssef et al. Stem Cells International
- A phase I study of AVE1642, a human monoclonal antibody–blocking insulin-like growth factor-1 receptor (IGF-1R), given as a single agent and in combination with sorafenib as first-line therapy in patients with advanced hepatocellular carcinoma (HCC).
- (2017) S. J. Faivre et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II study of cixutumumab (IMC-A12, NSC742460; C) in hepatocellular carcinoma (HCC).
- (2017) G. K. Abou-Alfa et al. JOURNAL OF CLINICAL ONCOLOGY
- MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways
- (2016) Yanmin Xu et al. CANCER LETTERS
- Molecular mechanisms of hepatitis C virus–induced hepatocellular carcinoma
- (2016) T. Vescovo et al. CLINICAL MICROBIOLOGY AND INFECTION
- IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models
- (2016) Iris Martinez-Quetglas et al. GASTROENTEROLOGY
- SIRT1-mediated transcriptional regulation of SOX2 is important for self-renewal of liver cancer stem cells
- (2016) Limei Liu et al. HEPATOLOGY
- The Relationship of Insulin-Like Growth Factor 2 to Fetal Growth and Adiposity
- (2016) Rachel Kadakia et al. Hormone Research in Paediatrics
- EpCAM-regulated intramembrane proteolysis induces a cancer stem cell-like gene signature in hepatitis B virus-infected hepatocytes
- (2016) Saravana Kumar Kailasam Mani et al. JOURNAL OF HEPATOLOGY
- Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis
- (2016) Xue Wang et al. JOURNAL OF HEPATOLOGY
- The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013
- (2016) Jeffrey D Stanaway et al. LANCET
- Cytokine Changes following Acute Ethanol Intoxication in Healthy Men: A Crossover Study
- (2016) Sudan Prasad Neupane et al. MEDIATORS OF INFLAMMATION
- The Hepatitis Viral Status in Patients With Hepatocellular Carcinoma
- (2016) Il-Chi Chang et al. MEDICINE
- Protein misfolding in the endoplasmic reticulum as a conduit to human disease
- (2016) Miao Wang et al. NATURE
- Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma
- (2016) Te-Sheng Chang et al. PLoS One
- Obesity Statistics
- (2016) Kristy Breuhl Smith et al. PRIMARY CARE
- The role of pluripotency factors to drive stemness in gastrointestinal cancer
- (2016) Martin Müller et al. Stem Cell Research
- Liver cancer stem cell markers: Progression and therapeutic implications
- (2016) Jing-Hui Sun et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Challenges of advanced hepatocellular carcinoma
- (2016) Stefano Colagrande et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Synergistic activity of vorinostat combined with gefitinib but not with sorafenib in mutant KRAS human non-small cell lung cancers and hepatocarcinoma
- (2016) Victor Jeannot et al. OncoTargets and Therapy
- MicroRNA-486-5p enhances hepatocellular carcinoma tumor suppression through repression of IGF-1R and its downstream mTOR, STAT3 and c-Myc
- (2016) Rana Ahmed Youness et al. Oncology Letters
- LncBRM initiates YAP1 signalling activation to drive self-renewal of liver cancer stem cells
- (2016) Pingping Zhu et al. Nature Communications
- Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectives
- (2016) Ricardo Costa et al. Drug Design Development and Therapy
- C-terminal truncated hepatitis B virus X protein promotes hepatocellular carcinogenesis through induction of cancer and stem cell-like properties
- (2016) Kai-Yu Ng et al. Oncotarget
- Matrix stiffness-mediated effects on stemness characteristics occurring in HCC cells
- (2016) Yang You et al. Oncotarget
- IGF-II induced by hepatitis B virus X protein regulates EMT via SUMO mediated loss of E-cadherin in mice
- (2016) Hye-Lin Ha et al. Oncotarget
- Hepatocellular carcinoma
- (2016) Josep M. Llovet et al. Nature Reviews Disease Primers
- Insulin-like Growth Factor 1 Signaling Axis Meets p53 Genome Protection Pathways
- (2016) Haim Werner et al. Frontiers in Oncology
- Multitargeting strategy using lenvatinib and golvatinib: Maximizing anti-angiogenesis activity in a preclinical cancer model
- (2015) Youya Nakazawa et al. CANCER SCIENCE
- The Long Noncoding RNA lncTCF7 Promotes Self-Renewal of Human Liver Cancer Stem Cells through Activation of Wnt Signaling
- (2015) Yanying Wang et al. Cell Stem Cell
- The Cancer Stem Cell Niche: How Essential Is the Niche in Regulating Stemness of Tumor Cells?
- (2015) Vicki Plaks et al. Cell Stem Cell
- Activation of IL6/IGFIR Confers Poor Prognosis of HBV-Related Hepatocellular Carcinoma through Induction of OCT4/NANOG Expression
- (2015) T.-S. Chang et al. CLINICAL CANCER RESEARCH
- Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma
- (2015) Victoria Tovar et al. GUT
- Resistance to multikinase inhibitor actions mediated by insulin like growth factor-1
- (2015) Catia Lippolis et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Paracrine Factors of Human Fetal MSCs Inhibit Liver Cancer Growth Through Reduced Activation of IGF-1R/PI3K/Akt Signaling
- (2015) Yulyana Yulyana et al. MOLECULAR THERAPY
- Targeting colorectal cancer via its microenvironment by inhibiting IGF-1 receptor-insulin receptor substrate and STAT3 signaling
- (2015) E Sanchez-Lopez et al. ONCOGENE
- RUNX3 is a novel negative regulator of oncogenic TEAD–YAP complex in gastric cancer
- (2015) Y Qiao et al. ONCOGENE
- Daintain/AIF-1 accelerates the activation of insulin-like growth factor-1 receptor signaling pathway in HepG2 cells
- (2015) SHAOHUI JIA et al. ONCOLOGY REPORTS
- AMPK interacts with β-catenin in the regulation of hepatocellular carcinoma cell proliferation and survival with selenium treatment
- (2015) SONG YI PARK et al. ONCOLOGY REPORTS
- Transcriptional activation of the IGF-II/IGF-1R axis and inhibition of IGFBP-3 by miR-155 in hepatocellular carcinoma
- (2015) HEND M. EL TAYEBI et al. Oncology Letters
- Effect of hypoxia on hypoxia inducible factor-1α, insulin-like growth factor I and vascular endothelial growth factor expression in hepatocellular carcinoma HepG2 cells
- (2015) QIANG LIU et al. Oncology Letters
- Insulin-Like Growth Factor System in Cancer: Novel Targeted Therapies
- (2015) Varsha P. Brahmkhatri et al. Biomed Research International
- Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies
- (2014) F. Turati et al. ANNALS OF ONCOLOGY
- Prevalence of Aflatoxin Induced p53 Mutation at Codon 249 (R249s) in Hepatocellular Carcinoma Patients with and without Hepatitis B Surface Antigen (HBsAg)
- (2014) Salyavit Chittmittrapap et al. Asian Pacific Journal of Cancer Prevention
- Hippo Pathway Activity Influences Liver Cell Fate
- (2014) Dean Yimlamai et al. CELL
- STAT3 Mediates Regorafenib-Induced Apoptosis in Hepatocellular Carcinoma
- (2014) W.-T. Tai et al. CLINICAL CANCER RESEARCH
- Hepatocellular Carcinoma: Reasons for Phase III Failure and Novel Perspectives on Trial Design
- (2014) J. M. Llovet et al. CLINICAL CANCER RESEARCH
- Hepatitis B virus X protein promotes P3 transcript expression of the insulin-like growth factor 2 gene via inducing hypomethylation of P3 promoter in hepatocellular carcinoma
- (2014) Shaohui Tang et al. LIVER INTERNATIONAL
- Unknown
- (2014) Anastassios Philippou et al. MOLECULAR MEDICINE
- Oncogenic transformation of diverse gastrointestinal tissues in primary organoid culture
- (2014) Xingnan Li et al. NATURE MEDICINE
- IGFBP7, a novel tumor stroma marker, with growth-promoting effects in colon cancer through a paracrine tumor–stroma interaction
- (2014) C Rupp et al. ONCOGENE
- Maintenance of Stemness in Oxaliplatin-Resistant Hepatocellular Carcinoma Is Associated with Increased Autocrine of IGF1
- (2014) Yang Bu et al. PLoS One
- HCC Development Is Associated to Peripheral Insulin Resistance in a Mouse Model of NASH
- (2014) Samuele De Minicis et al. PLoS One
- The cancer stem cell niche: cross talk between cancer stem cells and their microenvironment
- (2014) Jun Ye et al. TUMOR BIOLOGY
- Picropodophyllin and sorafenib synergistically suppress the proliferation and motility of hepatocellular carcinoma cells
- (2014) MINORU TOMIZAWA et al. Oncology Letters
- Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling
- (2014) Wan-Jiun Chen et al. Nature Communications
- Minireview: Nuclear Insulin and Insulin-like Growth Factor-1 Receptors: A Novel Paradigm in Signal Transduction
- (2013) Rive Sarfstein et al. ENDOCRINOLOGY
- Treatment of patients with dual hepatitis C and B by peginterferon α and ribavirin reduced risk of hepatocellular carcinoma and mortality
- (2013) Chun-Jen Liu et al. GUT
- A phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinoma
- (2013) Ghassan K. Abou-Alfa et al. JOURNAL OF HEPATOLOGY
- Epidemiology and natural history of HCV infection
- (2013) Behzad Hajarizadeh et al. Nature Reviews Gastroenterology & Hepatology
- Increased Expression of Yes-Associated Protein 1 in Hepatocellular Carcinoma with Stemness and Combined Hepatocellular-Cholangiocarcinoma
- (2013) Gi Jeong Kim et al. PLoS One
- HBV Induced HCC: Major Risk Factors from Genetic to Molecular Level
- (2013) Ambreen Ayub et al. Biomed Research International
- The Regulation of IGF-1 Gene Transcription and Splicing during Development and Aging
- (2013) A. M. Oberbauer Frontiers in Endocrinology
- Insulin-Like Growth Factor Signaling as a Therapeutic Target in Pancreatic Cancer
- (2012) Simon Rieder et al. Anti-Cancer Agents in Medicinal Chemistry
- Cytokines in alcoholic liver disease
- (2012) Leon An et al. ARCHIVES OF TOXICOLOGY
- Association Between Nonalcoholic Fatty Liver Disease and Risk for Hepatocellular Cancer, Based on Systematic Review
- (2012) Donna L. White et al. Clinical Gastroenterology and Hepatology
- Insulin-like growth factor-binding protein-6 and cancer
- (2012) Leon A. Bach et al. CLINICAL SCIENCE
- Insulin/IGF signaling drives cell proliferation in part via Yorkie/YAP
- (2012) Katrin Straßburger et al. DEVELOPMENTAL BIOLOGY
- The Insulin-Like Growth Factor System in Cancer
- (2012) S. John Weroha et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma
- (2012) Juanjuan Shan et al. HEPATOLOGY
- EGFR activation is a potential determinant of primary resistance of hepatocellular carcinoma cells to sorafenib
- (2012) Zakaria Ezzoukhry et al. INTERNATIONAL JOURNAL OF CANCER
- IGFBP3 impedes aggressive growth of pediatric liver cancer and is epigenetically silenced in vascular invasive and metastatic tumors
- (2012) Ivonne Regel et al. Molecular Cancer
- Excess Body Mass Index and Risk of Liver Cancer: A Nonlinear Dose-Response Meta-Analysis of Prospective Studies
- (2012) Rui Rui et al. PLoS One
- Cancer Stem Cells Stemness Transcription Factors Expression Correlates with Breast Cancer Disease Stage
- (2012) Panagiotis Apostolou et al. Current Stem Cell Research & Therapy
- Daintain/AIF-1 promotes breast cancer cell migration by up-regulated TNF-α via activate p38 MAPK signaling pathway
- (2011) Tao Li et al. BREAST CANCER RESEARCH AND TREATMENT
- Cancer Stem Cell Niche: The Place to Be
- (2011) T. Borovski et al. CANCER RESEARCH
- Insulin-like Growth Factor-Binding Protein-7 Functions as a Potential Tumor Suppressor in Hepatocellular Carcinoma
- (2011) D. Chen et al. CLINICAL CANCER RESEARCH
- Regulation of Cancer Stem Cells by Cytokine Networks: Attacking Cancer's Inflammatory Roots
- (2011) H. Korkaya et al. CLINICAL CANCER RESEARCH
- Gefitinib resistance in HCC mahlavu cells: Upregulation of CD133 expression, activation of IGF-1R signaling pathway, and enhancement of IGF-1R nuclear translocation
- (2011) Adam S. Bodzin et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Targeting insulin-like growth factor axis in hepatocellular carcinoma
- (2011) Jennifer Wu et al. Journal of Hematology & Oncology
- Yki/YAP, Sd/TEAD and Hth/MEIS Control Tissue Specification in the Drosophila Eye Disc Epithelium
- (2011) Tianyi Zhang et al. PLoS One
- Serum IGFBP-3 is a more effective predictor than IGF-1 and IGF-2 for the development of hepatocellular carcinoma in patients with chronic HCV infection
- (2011) EIMAN ALEEM et al. Oncology Letters
- Normal values of serum IGF-1 in adults: results from a Brazilian population
- (2010) Pedro Weslley Rosario Arquivos Brasileiros de Endocrinologia e Metabologia
- Transcriptional down-regulation of IGFBP-3 in human hepatocellular carcinoma cells is mediated by the binding of TIA-1 to its AT-rich element in the 3′-untranslated region
- (2010) Kothandharaman Subramaniam et al. CANCER LETTERS
- Type 1 Insulin-like Growth Factor Receptor Translocates to the Nucleus of Human Tumor Cells
- (2010) T. Aleksic et al. CANCER RESEARCH
- MicroRNA: Biogenesis, Function and Role in Cancer
- (2010) Leigh-Ann MacFarlane et al. CURRENT GENOMICS
- Hippo signaling: growth control and beyond
- (2010) G. Halder et al. DEVELOPMENT
- The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version
- (2010) B. Zhao et al. GENES & DEVELOPMENT
- The Hepatitis B Virus X Protein Modulates Hepatocyte Proliferation Pathways To Stimulate Viral Replication
- (2010) T. L. Gearhart et al. JOURNAL OF VIROLOGY
- Viral hepatitis and HIV co-infection
- (2009) Vincent Soriano et al. ANTIVIRAL RESEARCH
- Expression of a protease-resistant insulin-like growth factor-binding protein-4 inhibits tumour growth in a murine model of breast cancer
- (2009) A J Ryan et al. BRITISH JOURNAL OF CANCER
- Sorafenib
- (2009) Gillian M. Keating et al. DRUGS
- Cixutumumab
- (2009) Kevin P McKian et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Discovery of OSI-906: a selective and orally efficacious dual inhibitor of the IGF-1 receptor and insulin receptor
- (2009) Mark J Mulvihill et al. Future Medicinal Chemistry
- TEADs Mediate Nuclear Retention of TAZ to Promote Oncogenic Transformation
- (2009) Siew Wee Chan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Daintain/AIF-1 promotes breast cancer proliferation via activation of the NF-κB/cyclin D1 pathway and facilitates tumor growth
- (2008) Shou Liu et al. CANCER SCIENCE
- The Expression of Hypoxia-Inducible Factor-1α in Hepatitis B Virus-Related Hepatocellular Carcinoma: Correlation with Patients’ Prognosis and Hepatitis B Virus X Protein
- (2008) Huahong Xie et al. DIGESTIVE DISEASES AND SCIENCES
- TEAD mediates YAP-dependent gene induction and growth control
- (2008) B. Zhao et al. GENES & DEVELOPMENT
- Molecular targeted therapies in hepatocellular carcinoma
- (2008) Josep M. Llovet et al. HEPATOLOGY
- Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins
- (2008) Marta Guix et al. JOURNAL OF CLINICAL INVESTIGATION
- Oxidative stress in alcoholic liver disease: Role of NADPH oxidase complex
- (2008) Samuele De Minicis et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started